AQHA Racing Challenge Implements Clenbuterol Testing: AQHA 10/29/15

By: Press Release Starting in 2016, horses in all regional Challenge races will be subject to hair testing for clenbuterol. In the American Quarter Horse Association’s continuing and ongoing efforts to further the safety and welfare of our horses, horsemen and industry, and to assure fairness of competition, AQHA will be implementing hair testing for

NY Rule Impacts Testing for Claimed Horses: The Blood-Horse 10/25/15

By: Tom Precious The state of New York, citing costs savings, is considering a plan to halt a practice in which the state, at its expense, tests all claimed horses to check for the presence of drugs or other substances. The New York State Gaming Commission is set to adopt a proposed rule Oct. 26

CHRB Moves Forward on Altering Drug Policy: The Blood-Horse 10/22/15

By: Jeremy Balan The California Horse Racing Board took steps toward new guidelines for medication violators that would prevent those violators from transferring horses to one of their employees when under suspension, during its Oct. 22 meeting at Santa Anita Park. Under the new proposal, the violating trainer would have to be suspended for more

TVMDL Receives Interim Accreditation From RMTC: The Horse 10/20/15

By: Edited Press Release The Texas A&M Veterinary Medical Diagnostic Laboratory (TVMDL) Drug Testing Laboratory received interim accreditation from the Racing Medication and Testing Consortium (RMTC) board at the group's October meeting. The laboratory is only the seventh such to achieve this status. The laboratory annually performs more than 3,500 tests for livestock and 7,400

CHRB Investigates Cobalt Overage Related To Supplement: Paulick Report 10/17/15

By: Paulick Report Staff The California Horse Racing Board released the following Friday: The California Horse Racing Board recently investigated a case of elevated cobalt in a thoroughbred. This overage appears to be related to the use of Finish Line Iron Power – a fairly new supplement with a high cobalt concentration reported at 21.6mg

RMTC Examining Truesdail Lab After Recent Site Visit: Paulick Report 10/16/15

By: Paulick Report Staff Truesdail Laboratories, which has been the source of controversy since a quality check by the Indiana Horse Racing Commission this summer, is under scrutiny by the Racing Medication and Testing Consortium, according to the Daily Racing Form. The RMTC has sent a report to lab officials outlining concerns about its operations following

RMTC BOARD AMENDS ITS LIST OF CONTROLLED THERAPEUTIC MEDICATIONS, RECEIVES UPDATE ON NATIONAL UNIFORM MEDICATION PROGRAM, GRANTS INTERIM ACCREDITATION TO TEXAS A&M LABORATORY

NEWS RELEASE October 15, 2015 Contact: Hallie Roach Lewis (859) 224-2848 RMTC BOARD AMENDS ITS LIST OF CONTROLLED THERAPEUTIC MEDICATIONS, RECEIVES UPDATE ON NATIONAL UNIFORM MEDICATION PROGRAM, GRANTS INTERIM ACCREDITATION TO TEXAS A&M LABORATORY At its October 13 meeting in Atlanta, GA, the board of directors of the Racing Medication and Testing Consortium (RMTC) took

RMTC STATEMENT ON METHOCARBAMOL (ROBAXIN) THRESHOLD/ TREATMENT PROTOCOLS

NEWS RELEASE October 8, 2015 Contact: Dionne Benson, Executive Director, RMTC, (859) 224-2844 RMTC STATEMENT ON METHOCARBAMOL (ROBAXIN) THRESHOLD/ TREATMENT PROTOCOLS The Kentucky Horse Racing Commission recently suspended trainer Graham Motion for five days and fined him $500 for a medication overage involving the winner Kitten’s Point in Keeneland’s Bewitch Stakes. Kentucky officials determined that Kitten's